34 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... areas Preferred Therapy ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Hypoxemia - Workup and Management ... Aspiration, Flash Pulmonary ... Bronchospasm, Pulmonary ... edema), Lung Exam, POCUS ... PPI Oxygen Therapy
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
efficacy of this therapy ... Preferred Therapy ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
• Recommend pharmacologic ... therapy • Education ... measures, fall prevention ... benefits and risks of medications ... Treatment #Algorithm #Management
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment ... Chronic Obstructive Pulmonary ... Disease Initial medical ... Treatment #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
days) Preferred Therapy ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
mm3 Preferred Therapy ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Biologic therapy for eosinophilic asthma 
• Mepolizumab (Nucala) 
  • Anti-lL-5, 100 mg SQ q4
Biologic therapy ... asthma #Biologic #therapy ... #Medications #pharmacology ... #pulmonary #management
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... opportunistic #infections #HIVAIDS ... #management #pharmacology ... #pharmacology